Summary
The global generics market has grown at a rate of 20% in 2005; which is four times that of patented drugs and over three times that of pharmaceutical market. It is estimated to grow at a CAGR of 13.62% during the five-year period 2006-10. The market growth has been triggered by the rising number of patent expiries of blockbuster drugs and increasing healthcare expenditure. The US has the largest generics market and account to 44% of the global generics market. Teva Pharmaceuticals, based in Israel is the market leader in this industry followed by Sandoz
Scope Of The Report
This report discusses in detail about the major generic markets while giving information on their market size, recent trends, major players (15 major generic companies have been profiled with information on their business and financial profile, key strategies, R&D pipeline and outlook for the company.), generics pricing and outlook for the market. The report also analyses the factors that drive the growth of the generics industry, Overview of the generics industry in terms of size, geographical and therapeutic segmentation., Top 10 products in world's largest generics market, Issues & Challenges, Critical success factors, Growth Drivers, Mergers & Acquisitions, Major Markets( North America, Europe and Asia Pacific), Emergence of India as an important player in global generics industry, Amount & Area of R&D spend of major generic companies, Regulations governing generics, key patent expiries in the future, Outlook for the global generics industry for the next five years, FOR WHOM - , Lifesciences companies (Bulk drugs, Formulations and Biopharma), Govt departments & agencies working in Pharma, Consultants, Associations & Consortia of the industry, Research Institutions, Education Institutes, No of Pages : 127, List of Tables : 14, List of Figures : 32
|
